Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Effectiveness and feasibility of robotic gastric neurostimulator placement in patients with refractory gastroparesis

Effectiveness and feasibility of robotic gastric neurostimulator placement in patients with... Gastric neurostimulation (GNS) with Enterra® therapy device (Medtronic, Minneapolis, MN) appears as the last resort for patients with refractory gastroparesis. Currently, the device has Humanitarian Use status by Food and Drug Administration, thereby requiring further investigation. We aim to describe its feasibility and clinical outcomes using robotic technique. From June 2014 to September 2016, 15 consecutive patients underwent robotic insertion of Enterra® device. Patient demographics, comorbidities, and clinical outcomes including mortality, length of stay, readmission rates, reoperation and complications were retrospectively collected. Patients were also assessed based on a validated 14-point questionnaire regarding satisfaction with the operation, quality of life and symptomatic relief. Mean age was 41.6 years ± 13.8 and there were 11 females (73.3%). No mortality was reported. The annual hospital admissions were reduced after GNS (2.5 ± 4.1 vs. 3.6 ± 4.4, p = 0.004). The frequency of bloating (p = 0.029) and severity of emesis (p = 0.038), early satiety (p = 0.042) and bloating (p = 0.031) were reduced after GNS. The severity and frequency total scores were also improved after GNS (12.6 ± 1.4 vs. 18.1 ± 2.7, p = 0.008 and 12.9 ± 2.2 vs. 16.1 ± 1.1, p = 0.016, respectively). This is the first report describing the clinical experience with robotic insertion of GNS device. This approach is safe and feasible and seems to have similar long-term outcomes as laparoscopic technique. Potential advantages to robotic technique include enhanced dexterity and suturing of the device within gastric wall. Further experience with large prospective studies and randomized clinical trials may be warranted. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Robotic Surgery Springer Journals

Effectiveness and feasibility of robotic gastric neurostimulator placement in patients with refractory gastroparesis

Download PDF
8 pages

Loading next page...
 
/lp/springer_journal/effectiveness-and-feasibility-of-robotic-gastric-neurostimulator-eUh2nzdFj1
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer-Verlag London Ltd.
Subject
Medicine & Public Health; Minimally Invasive Surgery; Surgery; Urology
ISSN
1863-2483
eISSN
1863-2491
DOI
10.1007/s11701-017-0732-y
pmid
28730536
Publisher site
See Article on Publisher Site

Abstract

Gastric neurostimulation (GNS) with Enterra® therapy device (Medtronic, Minneapolis, MN) appears as the last resort for patients with refractory gastroparesis. Currently, the device has Humanitarian Use status by Food and Drug Administration, thereby requiring further investigation. We aim to describe its feasibility and clinical outcomes using robotic technique. From June 2014 to September 2016, 15 consecutive patients underwent robotic insertion of Enterra® device. Patient demographics, comorbidities, and clinical outcomes including mortality, length of stay, readmission rates, reoperation and complications were retrospectively collected. Patients were also assessed based on a validated 14-point questionnaire regarding satisfaction with the operation, quality of life and symptomatic relief. Mean age was 41.6 years ± 13.8 and there were 11 females (73.3%). No mortality was reported. The annual hospital admissions were reduced after GNS (2.5 ± 4.1 vs. 3.6 ± 4.4, p = 0.004). The frequency of bloating (p = 0.029) and severity of emesis (p = 0.038), early satiety (p = 0.042) and bloating (p = 0.031) were reduced after GNS. The severity and frequency total scores were also improved after GNS (12.6 ± 1.4 vs. 18.1 ± 2.7, p = 0.008 and 12.9 ± 2.2 vs. 16.1 ± 1.1, p = 0.016, respectively). This is the first report describing the clinical experience with robotic insertion of GNS device. This approach is safe and feasible and seems to have similar long-term outcomes as laparoscopic technique. Potential advantages to robotic technique include enhanced dexterity and suturing of the device within gastric wall. Further experience with large prospective studies and randomized clinical trials may be warranted.

Journal

Journal of Robotic Surgery – Springer Journals

Published: Jul 20, 2017

References

  • Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes 1995–2004
    Wang, Y; Fisher, R; Parkman, H
  • Clinical guideline: management of gastroparesis
    Camilleri, M; Parkman, H; Shafi, MA; Abell, TL; Gerson, L
  • Idiopathic gastroparesis
    Parkman, H
  • Diabetic gastroparesis
    Camilleri, M
  • Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation
    Khashab, M; Besharati, S; Ngamruengphong, S; Kumbhari, V; Zein, M; Stein, M; Tieu, A; Mullin, GE; Dhalla, S; Nandwani, MC; Singh, V; Canto, MI; Kalloo, AN; Clarke, JO
  • Pyloroplasty for refractory gastroparesis
    Mancini, S; Angelo, J; Peckler, Z; Philip, FH; Farah, KF
  • High-frequency gastric electrical stimulation for the treatment of gastroparesis: a meta-analysis
    O’Grady, G; Egbuji, J; Du, P; Cheng, LK; Pullan, AJ; Windsor, JA
  • Gastric neuromodulation with enterra system for nausea and vomiting in patients with gastroparesis
    Yin, J; Abell, T; McCallum, R; Chen, JD
  • Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study
    McCallum, RW; Snape, W; Brody, F; Wo, J; Parkman, HP; Nowak, T
  • Is symptom relief associated with reduction in gastric retention after gastric electrical stimulation treatment in patients with gastroparesis? A sensitivity analysis with logistic regression models
    Hou, Q; Lin, Z; Mayo, MS; Sarosiek, I; Gajewski, BJ; McCallum, RW
  • Predictive factors for clinical improvement with Enterra gastric electrical stimulation treatment for refractory gastroparesis
    Maranki, J; Lytes, V; Meilahn, JE; Friedeberg, FK; Fisher, RS; Parkman, HP
  • Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis
    Lin, Z; Sarosiek, I; Forster, J; McCallum, RW
  • Gastric electrical stimulation for medically refractory gastroparesis
    Abell, T; McCallum, R; Hocking, M; Koch, K; Abrahamsson, H; Leblanc, I; Lindberg, G; Konturek, J; Nowak, T; Quingley, EM; Tougas, G; Starkebaum, W
  • Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers
    Anand, C; Al-Juburi, A; Familoni, B; Rashed, H; Cutts, T; Abidi, N; Johnson, WD; Minocha, A; Abell, TL
  • Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years
    McCallum, R; Lin, Z; Forster, J
  • Further experience with gastric stimulation to treat drug refractory gastroparesis
    Forster, J; Sarosiek, I; Lin, Z; Durham, S; Denton, S; Roeser, K; McCallum, RW
  • Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis
    Parkman, HP; Yates, KP; Hasler, WL; Nguyan, L; Pasricha, PJ; Snape, WJ; Farrugia, G; Calles, J; Koch, KL; Abell, TL; McCallum, RW; Petito, D; Parrish, CR; Duffy, F; Lee, L; Unalp-Arida, A; Tonascia, J; Hamilton, F
  • The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis
    Janssen, P; Harris, MS; Jones, M; Masaoka, T; Farré, R; Tornblom, H; Oudenhove, L; Simrén, M; Tack, J
  • Completion gastrectomy for refractory gastroparesis following surgery for peptic ulcer disease. Long-term follow-up with subjective and objective parameters
    McCallum, R; Polepalle, S; Schirmer, B
  • Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis
    Ezzeddine, D; Jit, R; Katz, N; Gopalswamy, N; Bhutani, MS
  • Botulinum toxin for the treatment of gastroparesis: a preliminary report
    Lacy, BE; Zayat, EN; Crowell, MD; Schuster, MM
  • Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis
    Bromer, MQ; Friedenberg, F; Miller, LS; Fisher, RS; Swartz, K; Parkman, HP
  • Botulinum toxin A for the treatment of delayed gastric emptying
    Friedenberg, F; Palit, A; Parkman, HP; Hanlon, A; Nelson, DB
  • Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?
    Cutts, TF; Luo, J; Starkebaum, W; Rashed, H; Abell, TL
  • Assessing the cost effectiveness of robotics in urological surgery—a systematic review
    Ahmet, K; Ibrahim, A; Wang, TT; Khan, N; Challacombe, B; Khan, MS; Dasgupta, P
  • Robotic implantation of gastric electrical stimulation electrodes for gastroparesis
    Gould, J; Dholakia, C
  • The long-term efficacy and safety of pyloroplasty combined with gastric electrical stimulation therapy in gastroparesis
    Davis, BR; Sarosiek, I; Bashashati, M; Alvarado, B; McCallum, RW
  • The addition of pyloroplasty as a new surgical approach to enhance the effectiveness of gastric electrical stimulation therapy in patients with gastroparesis
    Sarosiek, I; Forster, J; Lin, Z; Cherry, S; Sarosiek, J; McCallum, R
  • The difficult patient with gastroparesis
    Tack, J